Disclosure Quest - Search SEC Filings

More options

Type of Offering

Amount To Be Raised

to

Filing Date

to

Type of Security

Industry

CIK Number

Principal Place Of Business

Found 5 results

Name	Type of Offering	Accepted Date
DepYmed Inc. See All Filings	D	2025-04-25 14:52:52 UTC
Amount To Be Raised $250,000 Associated Brokers / Dealers N/A CIK Number 0001851177 Filed Document 0001104659-25-039335 Exclusions or Exemptions 506b Accepted Date 2025-04-25 14:52:52 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
DepYmed Inc. See All Filings	D	2025-02-11 13:18:03 UTC
Amount To Be Raised $250,000 Associated Brokers / Dealers N/A CIK Number 0001851177 Filed Document 0001104659-25-011368 Exclusions or Exemptions 506b Accepted Date 2025-02-11 13:18:03 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
DepYmed Inc. See All Filings	D	2024-08-16 11:55:20 UTC
Amount To Be Raised $600,000 Associated Brokers / Dealers N/A CIK Number 0001851177 Filed Document 0001104659-24-090392 Exclusions or Exemptions 506b Accepted Date 2024-08-16 11:55:20 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
DepYmed Inc. See All Filings	D	2024-03-12 08:29:33 UTC
Amount To Be Raised $500,000 Associated Brokers / Dealers N/A CIK Number 0001851177 Filed Document 0001104659-24-033262 Exclusions or Exemptions 506b Accepted Date 2024-03-12 08:29:33 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
DepYmed Inc. See All Filings	D	2023-05-04 17:04:47 UTC
Amount To Be Raised $2,000,000 Associated Brokers / Dealers N/A CIK Number 0001851177 Filed Document 0001104659-23-056092 Exclusions or Exemptions 506b Accepted Date 2023-05-04 17:04:47 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity